Bio & Science

Latest

What Synthetic Embryos Can and Can’t Do, Now and in the Future

Magda Zernicka-Goetz and Nicole Neuman

Caltech Professor Magda Zernicka-Goetz explains recent progress in building 'synthetic' embryos from stem cells, their applications, and what they can't do.

How to Build a GPT-3 for Science

Josh Nicholson

A GPT-3-like AI model for science would accelerate innovation and improve reproducibility. Creating it will require us to unlock scientific publications.

AI’s Next Frontier: Brains on Demand

Patrick Mineault

AI-created models of the brain are emerging that have applications in art, advertising, and health. Adoption of AR and BCI will further enhance model utility.

The Glittering Treasure in Your Genome’s Junk

Rick Young, Jorge Conde, and Hanne Winarsky

A Q&A with MIT Professor Rick Young about the roles of the 98% of the human genome that does not code for proteins -- known as non-coding DNA or junk DNA.

Quantifying Disease Risk Using Genomics: the New Paradigm

Peter Donnelly, Vineeta Agarwala, and Lauren Richardson

How polygenic risk scores use genetics to predict your chance for common diseases and how this helps us shift from 'sick care' to preventative medicine.

Mid-year Recap: Web3 and Science Collide

Future Editorial

The first half of 2022 saw momentum gains for a movement at the intersection of web3 and science: decentralized science (DeSci).

Recognizing the Next CRISPR-Level Tech for Biology

Jennifer Doudna and Vijay Pande

A Q&A with Jennifer Doudna. She shares thoughts on recognizing game-changing biology tools, what she's struggling with, and what may never be engineerable.

The Two Things We’ll Need for the Next AlphaFold

Daphne Koller and Nicole Neuman

Daphne Koller explains why some fail the academia-to-biotech transition and identifies what we'll need for AlphaFold-level successes across biology and biotech.

Can Synthetic Biology and Pond Scum Deliver Carbon-Neutral Manufacturing?

Nusqe Spanton and Nicole Neuman

A Q&A with Nusqe Spanton, founder and CEO of Provectus Algae.

A Guide to Decentralized Biotech

Jocelynn Pearl

Shared lab space, collaborative projects, DAO-funded research, and other signs of big structural change in this traditionally centralized industry.